Do you need guidance for negotiating and drafting a non-jurisdictional settlement agreement and release of claims for a single-plaintiff employment dispute? Use our newly published playbook, Settlement...
In May 2025, the SEC’s Division of Trading and Markets, along with a separate statement by SEC Commissioner Peirce, released FAQs that provide long-awaited clarity on the regulatory treatment of...
Both the House and Senate versions of the One Big Beautiful Bill Act (OBBBA), passed by the House on May 22, 2025, and the Senate on July 1, 2025, phase out tax credits for wind, solar, and electric vehicle...
Playbooks help attorneys review, draft, and negotiate contracts efficiently and consistently by comparing favored contract language with fallback language and providing drafting guidance and negotiation...
In the intricate world of M&A transactions, tax considerations often determine deal viability, structure optimization, and ultimate value creation. Navigate the complex landscape where strategic tax...
* The views expressed in externally authored materials linked or published on this site do not necessarily reflect the views of LexisNexis Legal & Professional.
Equity cure rights permit a holding company, sponsor, or other shareholder to make an investment in the borrower, thereby providing cash proceeds that allow the borrower to comply with financial maintenance covenants in the credit agreement and preventing or repairing a breach of those covenants. While the prevalence of equity cure rights during 2023 remained steady when compared to credit agreements filed in 2022, new trends are developing. Read this practice note providing an overview of recent trends in equity cure rights to learn more!
Read now »
Related Content
Practical Guidance Updates Featuring the latest updates from your Practical Guidance account.
PRACTICAL GUIDANCE CUSTOMER EMAIL EDITION ON THE WEB
Experience results today with practical guidance, legal research, and data-driven insights—all in one place.Experience Lexis+